Know When to Use Different Immune Thrombocytopenia (ITP) Treatments

November 2019

You'll get questions about strategies to manage primary immune thrombocytopenia (ITP) in adults.

These patients have platelets under 100,000/mm3 not linked to an identifiable cause...such as heparin or other meds, infections, or lupus.

Assess bleeding risk and platelet count when considering treatment...and work closely with the hematologist.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote